Automated Filling Line produces pre-sterliized syringes.
Press Release Summary:
Designed for automated processing of up to 9,500 syringes/hr, FXS 2050 filling and closing machine minimizes need for manual interference, so risk of contamination is minimized. It incorporates peristaltic pumps, automated bag and tub opening system, program-controlled servo drives, as well as RIL-100 rod insertion labeling unit, USD-100 denester, and ZPS buffer system. Single syringe samples can be accessed and discharged directly. System enables production under cleanroom class A conditions.
Original Press Release:
Compact Filling Line for Pre-Sterilized Syringes with a Fully Automated Bag and Tub Opener
Fully automated processing of up to 9,500 syringes per hour
Reduced need for manual interference minimizes risk of contamination
Product filling, closing and extraction completely reproducible
Bosch Packaging Technology introduces its fully automated filling line for pre-sterilized syringes: the FXS 2050, designed for mid-range output. This slender line concept was developed specifically for manufacturers with limited production space.
At the core of the FXS 2050 filling and closing machine are its peristaltic pumps. Together with the fully automated bag (ABO) and tub (ATO) opening system it achieves an output of up to 9,500 syringes per hour. The reduced need for manual interference minimizes the risk of contamination. The program-controlled servo drives, precisely operating robotics and fewer form sets further reduce the contamination risk during production. The extraction of product samples functions automatically; single syringe samples can be accessed and discharged directly.
The bag and tub opening system is part of the fully automated solution for up-stream processes to prepare the tubs and syringe nests. Besides the output, the line focuses on pre-defined, secure and completely reproducible processes. Furthermore, integrated in the line is the RIL-100 rod insertion labeling unit, the USD-100 denester and the ZPS buffer system. All three units are supplied by Moeller & Devicon, a Bosch Packaging Technology company.
"Fully integrated filling and closing lines most effectively reduce the risk of contaminating sterile delivered syringes," says Klaus Ullherr, Product Manager for syringes at Bosch Packaging Technology. "With the compact FXS 2050 and the integrated solutions for up and down-stream processes, the entire filling and closing process for pre-sterilized syringes can be executed."
The FXS 2050 can also be integrated into a Restricted Access Barrier System (RABS) and enables production under cleanroom class A conditions. The compact design of the FXS 2050 makes it an intelligent solution to decrease total operating costs.
About Bosch Packaging Technology
Bosch Packaging Technology, based in Waiblingen (Germany), is one of the leading suppliers for holistic systems for packaging and process technol¬ogy. In 15 countries worldwide the company develops, produces and distributes modules and systems for the pharmaceutical, confectionery, and cosmetics industries, as well as other food and non-food industries. In 2008, 4,650 associates achieved a turnover of approximately 700 million euros. Learn more at www.boschpackaging.com.
Contact for press inquiries:
Christian Bosshard
Bosch Packaging Services AG
Rheinstrasse 36
CH-8212 Neuhausen
Phone: +41 52 674 67 71
Fax: +41 52 674 63 50
christian.bosshard@bosch.com
Switzerland
Contact for reader inquiries:
Product Management
Klaus Ullherr
Robert Bosch GmbH
Packaging Technology
Blaufelderstrasse 45
D-74564 Crailsheim
Phone: +49 7951 402 517
Fax: +49 7951 402 455
Email: klaus.ullherr@bosch.com
Germany
The Bosch Group is a leading global supplier of technology and services. According to preliminary figures, some 282,000 associates generated sales of roughly 45 billion euros in the areas of automotive and industrial technology, consumer goods, and building technology in fiscal 2008. The Bosch Group comprises Robert Bosch GmbH and its more than 300 subsidiaries and regional companies in over 60 countries. If its sales and service partners are included, then Bosch is represented in roughly 150 countries. This worldwide development, manufacturing, and sales network is the foundation for further growth. Each year, Bosch spends more than 3 billion euros for research and development, and applies for over 3,000 patents worldwide. With all its products and services, Bosch enhances the quality of life by providing solutions which are both innovative and beneficial.
The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as "Workshop for Precision Mechanics and Electrical Engineering." The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant up-front investments in the safeguarding of its future. Ninety-two percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust. The entrepreneurial ownership functions are carried out by the trust. The remaining shares are held by the Bosch family and by Robert Bosch GmbH.
Additional information can be accessed at www.bosch.com.
